These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 18544456

  • 1. Bowman-Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis.
    Touil T, Ciric B, Ventura E, Shindler KS, Gran B, Rostami A.
    J Neurol Sci; 2008 Aug 15; 271(1-2):191-202. PubMed ID: 18544456
    [Abstract] [Full Text] [Related]

  • 2. The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis.
    Gran B, Tabibzadeh N, Martin A, Ventura ES, Ware JH, Zhang GX, Parr JL, Kennedy AR, Rostami AM.
    Mult Scler; 2006 Dec 15; 12(6):688-97. PubMed ID: 17262995
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.
    Dai H, Ciric B, Zhang GX, Rostami A.
    J Neuroimmunol; 2012 Apr 15; 245(1-2):1-7. PubMed ID: 22365083
    [Abstract] [Full Text] [Related]

  • 4. Bowman-Birk Inhibitor attenuates experimental autoimmune encephalomyelitis by delaying infiltration of inflammatory cells into the CNS.
    Dai H, Ciric B, Zhang GX, Rostami A.
    Immunol Res; 2011 Dec 15; 51(2-3):145-52. PubMed ID: 22095543
    [Abstract] [Full Text] [Related]

  • 5. Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
    Safavi F, Rostami A.
    Exp Mol Pathol; 2012 Dec 15; 93(3):428-33. PubMed ID: 23022357
    [Abstract] [Full Text] [Related]

  • 6. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate.
    Wan XS, Serota DG, Ware JH, Crowell JA, Kennedy AR.
    Nutr Cancer; 2002 Dec 15; 43(2):167-73. PubMed ID: 12588697
    [Abstract] [Full Text] [Related]

  • 7. The Bowman-Birk inhibitor from soybeans as an anticarcinogenic agent.
    Kennedy AR.
    Am J Clin Nutr; 1998 Dec 15; 68(6 Suppl):1406S-1412S. PubMed ID: 9848508
    [Abstract] [Full Text] [Related]

  • 8. Bowman-Birk inhibitor concentrate suppresses experimental autoimmune neuritis via shifting macrophages from M1 to M2 subtype.
    Jin T, Yu H, Wang D, Zhang H, Zhang B, Quezada HC, Zhu J, Zhu W.
    Immunol Lett; 2016 Mar 15; 171():15-25. PubMed ID: 26791957
    [Abstract] [Full Text] [Related]

  • 9. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
    Zhang L, Wan XS, Donahue JJ, Ware JH, Kennedy AR.
    Nutr Cancer; 1999 Mar 15; 33(2):165-73. PubMed ID: 10368812
    [Abstract] [Full Text] [Related]

  • 10. Effects of Bowman-Birk inhibitor on rat colon carcinogenesis.
    Kennedy AR, Billings PC, Wan XS, Newberne PM.
    Nutr Cancer; 2002 Mar 15; 43(2):174-86. PubMed ID: 12588698
    [Abstract] [Full Text] [Related]

  • 11. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S, Pahan K.
    PLoS One; 2015 Mar 15; 10(1):e0116566. PubMed ID: 25569428
    [Abstract] [Full Text] [Related]

  • 12. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
    Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O.
    J Neuroinflammation; 2016 Feb 26; 13():48. PubMed ID: 26920550
    [Abstract] [Full Text] [Related]

  • 13. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
    Malkowicz SB, Liu SP, Broderick GA, Wein AJ, Kennedy AR, Levin RM.
    Neurourol Urodyn; 2003 Feb 26; 22(1):54-7. PubMed ID: 12478602
    [Abstract] [Full Text] [Related]

  • 14. Soybean-derived Bowman-Birk inhibitor inhibits neurotoxicity of LPS-activated macrophages.
    Li J, Ye L, Cook DR, Wang X, Liu J, Kolson DL, Persidsky Y, Ho WZ.
    J Neuroinflammation; 2011 Feb 15; 8():15. PubMed ID: 21324129
    [Abstract] [Full Text] [Related]

  • 15. IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis.
    Xie C, Ciric B, Yu S, Zhang GX, Rostami A.
    J Neuroimmunol; 2016 Feb 15; 291():59-69. PubMed ID: 26857496
    [Abstract] [Full Text] [Related]

  • 16. Proteases, protease inhibitors and radiation carcinogenesis.
    Kennedy AR.
    Int J Radiat Biol; 2023 Feb 15; 99(6):882-890. PubMed ID: 34325613
    [Abstract] [Full Text] [Related]

  • 17. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R, Vainshtein A, Stock A, Eilam R, From R, Shinder V, Arnon R.
    J Autoimmun; 2011 Nov 15; 37(3):228-41. PubMed ID: 21752599
    [Abstract] [Full Text] [Related]

  • 18. Effects of the Bowman-Birk protease inhibitor on survival of fibroblasts and cancer cells exposed to radiation and cis-platinum.
    Kennedy CW, Donahue JJ, Wan XS.
    Nutr Cancer; 1996 Nov 15; 26(2):209-17. PubMed ID: 8875558
    [Abstract] [Full Text] [Related]

  • 19. HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.
    Khan RS, Dine K, Luna E, Ahlem C, Shindler KS.
    Invest Ophthalmol Vis Sci; 2014 Aug 19; 55(9):5744-51. PubMed ID: 25139738
    [Abstract] [Full Text] [Related]

  • 20. Treatment of a relapse-remitting model of multiple sclerosis with opioid growth factor.
    Hammer LA, Zagon IS, McLaughlin PJ.
    Brain Res Bull; 2013 Sep 19; 98():122-31. PubMed ID: 23973432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.